The Global Kainic Acid Market is expected to grow at a significant CAGR during the forecast period 2022-2028.
Kainic acid is a cyclic analogue of L-glutamate that binds to the ionotropic kainic acid receptor and acts as an agonist. It was isolated and extracted from digenea simplex, a red alga that inhabits tropical and subtropical waters. It was originally known as digenic acid. However, to avoid confusion with other digenea derivatives, the name has been changed to kainic acid. Kainic acid was developed as an ascaricide to treat ascariasis, a disease caused by ascaris lumbricoides. Temporal lobe epilepsy models based on kainic acid have greatly supported our understanding of the molecular, cellular and pharmacological mechanisms underlying epilepsy development and seizures.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Kainic Acid Market at: https://www.orionmarketreports.com/request-sample/?id=73759
Market Segments
By Type:
- Low Purity(below 97%)
- Purity(above 97% And Below 99%)
- High Purity(above 99%)
- Others
By application:
- Epilepsy Treatment
- Neurological Research
- Others
Key Players
- R&d Systems
- Abcam
- Stemgent
- Cayman Chemical
- Santa Cruz Biotechnology
- Stemcell Technologies
- Alfa Chemistry
- Anward
- Race Chemical
- Glentham Life Sciences
- Abmole Bioscience
- Aurum Pharmatech Llc
Scope of the Report
The research study analyzes the global Kainic Acid industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
A full report of Global Kainic Acid Market is available at: https://www.orionmarketreports.com/kainic-acid-market/73759/
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Kainic Acid Market Report
1. What was the Kainic Acid Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Kainic Acid Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Kainic Acid Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Kainic Acid market.
- The market share of the global Kainic Acid market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Kainic Acid market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Kainic Acid market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
